<DOC>
	<DOCNO>NCT01495741</DOCNO>
	<brief_summary>This study assess asenapine ( Sycrest速 ) use participant bipolar disorder ; comparison make use risperidone ( RISPERDAL速CONSTA速 ) olanzapine ( Zyprexa速 ) . The occurrence identify potential clinically important risk also assess .</brief_summary>
	<brief_title>Post-Authorization Safety Surveillance Study Asenapine Participants With Bipolar Disorder ( P08307 )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Asenapine</mesh_term>
	<criteria>Inclusion Criteria Bipolar Disease Cohort : A diagnosis Bipolar Disorder Exclusion Criteria Bipolar Disease Cohort : Inclusion Criteria potential Schizophrenia Cohort : A diagnosis schizophrenia Exclusion Criteria potential Schizophrenia Cohort : A prior and/or concomitant diagnosis bipolar disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Mania</keyword>
	<keyword>Manic</keyword>
	<keyword>Depressive</keyword>
	<keyword>Manic Depressive</keyword>
</DOC>